Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Adv Mater ; 34(23): e2202063, 2022 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-35443084

RESUMO

Proton conduction underlies many important electrochemical technologies. A family of new proton electrolytes is reported: acid-in-clay electrolyte (AiCE) prepared by integrating fast proton carriers in a natural phyllosilicate clay network, which can be made into thin-film (tens of micrometers) fluid-impervious membranes. The chosen example systems (sepiolite-phosphoric acid) rank top among the solid proton conductors in terms of proton conductivities (15 mS cm-1 at 25 °C, 0.023 mS cm-1 at -82 °C), electrochemical stability window (3.35 V), and reduced chemical reactivity. A proton battery is assembled using AiCE as the solid electrolyte membrane. Benefitting from the wider electrochemical stability window, reduced corrosivity, and excellent ionic selectivity of AiCE, the two main problems (gassing and cyclability) of proton batteries are successfully solved. This work draws attention to the element cross-over problem in proton batteries and the generic "acid-in-clay" solid electrolyte approach with superfast proton transport, outstanding selectivity, and improved stability for room- to cryogenic-temperature protonic applications.

3.
ACS Appl Mater Interfaces ; 12(34): 38570-38583, 2020 Aug 26.
Artigo em Inglês | MEDLINE | ID: mdl-32786241

RESUMO

Solid electrolytes based on LiBH4 receive much attention because of their high ionic conductivity, electrochemical robustness, and low interfacial resistance against Li metal. The highly conductive hexagonal modification of LiBH4 can be stabilized via the incorporation of LiI. If the resulting LiBH4-LiI is confined to the nanopores of an oxide, such as Al2O3, interface-engineered LiBH4-LiI/Al2O3 is obtained that revealed promising properties as a solid electrolyte. The underlying principles of Li+ conduction in such a nanocomposite are, however, far from being understood completely. Here, we used broadband conductivity spectroscopy and 1H, 6Li, 7Li, 11B, and 27Al nuclear magnetic resonance (NMR) to study structural and dynamic features of nanoconfined LiBH4-LiI/Al2O3. In particular, diffusion-induced 1H, 7Li, and 11B NMR spin-lattice relaxation measurements and 7Li-pulsed field gradient (PFG) NMR experiments were used to extract activation energies and diffusion coefficients. 27Al magic angle spinning NMR revealed surface interactions of LiBH4-LiI with pentacoordinated Al sites, and two-component 1H NMR line shapes clearly revealed heterogeneous dynamic processes. These results show that interfacial regions have a determining influence on overall ionic transport (0.1 mS cm-1 at 293 K). Importantly, electrical relaxation in the LiBH4-LiI regions turned out to be fully homogenous. This view is supported by 7Li NMR results, which can be interpreted with an overall (averaged) spin ensemble subjected to uniform dipolar magnetic and quadrupolar electric interactions. Finally, broadband conductivity spectroscopy gives strong evidence for 2D ionic transport in the LiBH4-LiI bulk regions which we observed over a dynamic range of 8 orders of magnitude. Macroscopic diffusion coefficients from PFG NMR agree with those estimated from measurements of ionic conductivity and nuclear spin relaxation. The resulting 3D ionic transport in nanoconfined LiBH4-LiI/Al2O3 is characterized by an activation energy of 0.43 eV.

4.
J Gastrointest Oncol ; 9(3): 416-424, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-29998006

RESUMO

BACKGROUND: The correlation between DPYD*9A (c.85T>C) genotype and dihydropyrimidine dehydrogenase (DPD) deficiency clinical phenotype is controversial. Reference laboratories either did not perform DPYD*9A genotyping or have stopped DPYD*9A genotyping and limited genotyping to high-risk variants (DPYD*2A, DPYD*13 and DPYD*9B) only. This study explored DPYD*9A genotype and clinical phenotype correlation in patients with gastrointestinal (GI) malignancies treated with fluoropyrimidines. METHODS: Between 2011 and 2017, 67 patients with GI malignancies were genotyped for DPYD variants. Fluoropyrimidines-associated toxicity was graded according to the National Cancer Institute Common Terminology Criteria for Adverse Events (version 3.0). Fisher's exact test was used for statistical analysis. RESULTS: DPYD variants were identified in 17 out of 67 (25%) patients. One patient was homozygous for DPYD*9A variant and one patient was double heterozygous for DPYD*9A and DPYD*9B variants. In patients with identified DPYD variants, 13/17 (76%) patients had DPYD*9A variant, 3/17 (18%) patients had DPYD*2A variant and 2/17 (12%) patient had DPYD*9B variant. Only patients genotyped prior to 2015 were genotyped for DPYD*9A variant (N=28). Of those, 13/28 patients (46%) had DPYD*9A variant. Grade 3-4 diarrhea was associated with DPYD*9A variant in patients treated with full dose fluoropyrimidines (P=0.0055). CONCLUSIONS: In our cohort, DPYD*9A variant was the most common diagnosed variant. The correlation between DPYD*9A genotype and DPD deficiency in clinical phenotype was noticeable in patients who received full dose fluoropyrimidines as they all experienced grade 3-4 toxicities (diarrhea).

5.
Eur Spine J ; 26(8): 2204-2210, 2017 08.
Artigo em Inglês | MEDLINE | ID: mdl-28688061

RESUMO

STUDY DESIGN: Technical note. OBJECTIVE: We describe a novel technique of bilateral longitudinal sacral osteotomy allowing direct reduction of high pelvic incidence (PI) and correction of sagittal imbalance. METHODS: A 25-year-old female patient presented with a disabling lumbo-sacral kyphosis fused in situ through previous operations with residual low-grade wound infection and grade IV L5/S1 spondylolisthesis with severity index (SI) of 65%. A two-stage correction was performed. First anterior in situ fixation of the L4-L5-S1 segments was performed using a hollow modular anchorages (HMA) screw and L3/L4 anterior interbody cage. The second stage consisted of instrumentation of the lower lumbar spine and pelvis; placement of an S1 transverse K-wire as pivot point and bilateral longitudinal sacral osteotomy which allowed for gradual retroversion of the central sacrum relative to the pelvis. RESULTS: Sacrum was derotated by 30° which allowed to restore spinal sagittal balance and decrease SI by 15%. Postoperative recovery was complicated by a flare up of the pre-existing deep wound infection. CONCLUSIONS: Bilateral longitudinal sacral osteotomy appears to be a safe and efficient way of correcting the sagittal imbalance caused by an extremely high PI. Although technically demanding, it achieves good radiological and functional outcomes and avoids entering the spinal canal.


Assuntos
Cifose/cirurgia , Vértebras Lombares/cirurgia , Osteotomia/métodos , Pelve/patologia , Sacro/cirurgia , Fusão Vertebral/métodos , Adulto , Feminino , Humanos , Cifose/patologia
6.
Virchows Arch ; 461(3): 323-31, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22790664

RESUMO

Angioimmunoblastic T cell lymphoma (AITL) is a relatively rare peripheral T cell lymphoma derived from follicular T helper cells. AITL has a varied presentation, both clinically and morphologically. AITL can pose a diagnostic challenge as it may be difficult to identify and characterize the neoplastic cells among the polymorphous infiltrates composed of polyclonal B immunoblasts and plasma cells. In AITL, the reactive B cell and plasma cell proliferation is secondary to dysregulated secretion of cytokines such as interleukin-6 by the neoplastic follicular T helper cells. SPBIP is a condition of unknown etiopathogenesis characterized by systemic involvement by polyclonal B immunoblasts and plasma cells. We report two cases of AITL, which are presented with atypical findings making it difficult to diagnose. The cases had features similar to SPBIP. Our cases highlight the importance of screening cases of polyclonal plasmacytosis and SPBIP like cases for underlying AITL.


Assuntos
Linfócitos B/patologia , Linfadenopatia Imunoblástica/diagnóstico , Linfoma de Células T Periférico/diagnóstico , Idoso , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Transplante de Medula Óssea , Terapia Combinada , Diagnóstico Diferencial , Feminino , Humanos , Linfoma de Células T Periférico/tratamento farmacológico , Linfoma de Células T Periférico/cirurgia , Pessoa de Meia-Idade , Neoplasias Primárias Múltiplas , Plasmócitos , Recidiva , Transplante de Células-Tronco , Resultado do Tratamento
8.
J Exp Bot ; 58(5): 1109-18, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17220512

RESUMO

In roots, nitrate assimilation is dependent upon a supply of reductant that is initially generated by oxidative metabolism including the pentose phosphate pathway (OPPP). The uptake of nitrite into the plastids and its subsequent reduction by nitrite reductase (NiR) and glutamate synthase (GOGAT) are potentially important control points that may affect nitrate assimilation. To support the operation of the OPPP there is a need for glucose 6-phosphate (Glc6P) to be imported into the plastids by the glucose phosphate translocator (GPT). Competitive inhibitors of Glc6P uptake had little impact on the rate of Glc6P-dependent nitrite reduction. Nitrite uptake into plastids, using (13)N labelled nitrite, was shown to be by passive diffusion. Flux through the OPPP during nitrite reduction and glutamate synthesis in purified plastids was followed by monitoring the release of (14)CO(2) from [1-(14)C]-Glc6P. The results suggest that the flux through the OPPP is maximal when NiR operates at maximal capacity and could not respond further to the increased demand for reductant caused by the concurrent operation of NiR and GOGAT. Simultaneous nitrite reduction and glutamate synthesis resulted in decreased rates of both enzymatic reactions. The enzyme activity of glucose 6-phosphate dehydrogenase (G6PDH), the enzyme supporting the first step of the OPPP, was induced by external nitrate supply. The maximum catalytic activity of G6PDH was determined to be more than sufficient to support the reductant requirements of both NiR and GOGAT. These data are discussed in terms of competition between NiR and GOGAT for the provision of reductant generated by the OPPP.


Assuntos
Glucose-6-Fosfato/metabolismo , Ácido Glutâmico/biossíntese , Nitritos/metabolismo , Pisum sativum/metabolismo , Raízes de Plantas/citologia , Plastídeos/metabolismo , Elétrons , Nitrito Redutases/metabolismo , Oxirredução , Pisum sativum/citologia , Via de Pentose Fosfato/fisiologia , Raízes de Plantas/metabolismo
9.
Planta ; 223(4): 821-34, 2006 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-16200407

RESUMO

Nitrate assimilation in the model legume, Lotus japonicus, has been investigated using a variety of approaches. A gene encoding a nitrate-inducible nitrate reductase (NR) has been cloned and appears to be the only NR gene present in the genome. Most of the nitrate reductase activity (NRA) is found in the roots and the plant assimilates the bulk of its nitrogen in that tissue. We calculate that the observed rates of nitrate reduction are compatible with the growth requirement for reduced nitrogen. The NR mRNA, NRA and the nitrate content do not show a strong diurnal rhythm in the roots and assimilation continues during the dark period although export of assimilated N to the shoot is lower during this time. In shoots, the previous low NR activity may be further inactivated during the dark either by a phosphorylation mechanism or due to reduced nitrate flux coincident with a decreased delivery through the transpiration stream. From nitrate-sufficient conditions, the removal of nitrate from the external medium causes a rapid drop in hydraulic conductivity and a decline in nitrate and reduced-N export. Root nitrate content, NR and nitrate transporter (NRT2) mRNA decline over a period of 2 days to barely detectable levels. On resupply, a coordinated increase of NR and NRT2 mRNA, and NRA is seen within hours.


Assuntos
Lotus/metabolismo , Nitratos/metabolismo , Regulação Enzimológica da Expressão Gênica , Regulação da Expressão Gênica de Plantas , Genes de Plantas , Luz , Lotus/enzimologia , Lotus/genética , Nitrato Redutase (NADH)/genética , Nitrato Redutase (NADH)/metabolismo , Fotoperíodo , Proteínas de Plantas/genética , Proteínas de Plantas/metabolismo , Raízes de Plantas/enzimologia
10.
Eur J Biochem ; 269(3): 1006-11, 2002 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11846803

RESUMO

As an adaptation process to the growth retardation provoked by the presence of nonlethal concentrations of ergosterol biosynthesis inhibitors, Ustilago maydis alters the ratio of linoleic to oleic acid bound to plasma membrane complex lipids [Hernández, A., Cooke, D.T., Lewis, M. & Clarkson, D.T. (1997) Microbiology 143, 3165-3174]. This alteration increases plasma membrane H(+)-ATPase hydrolytic activity. Activation of H(+)-ATPase by the linoleic/oleic acid proportion is noncompetitive, nonessential and only involves changes in the maximum velocity of the pump. Optimum pH, affinity to MgATP and constants for the inhibition by vanadate and erythrosin B remain unchanged. This all indicates that activation of plasma membrane H(+)-ATPase by unsaturated fatty acids differs clearly from glucose-induced activation observed in yeast. Also, it is a physiologically relevant event similar to other, as yet uncharacterized, changes in plasma membrane H(+)-ATPase hydrolytic activity observed in plants and fungi, as part of an adaptation process to different stress conditions.


Assuntos
Membrana Celular/metabolismo , Ácidos Graxos Insaturados/metabolismo , ATPases Translocadoras de Prótons/metabolismo , Ustilago/metabolismo , Trifosfato de Adenosina/metabolismo , Ativação Enzimática/efeitos dos fármacos , Inibidores Enzimáticos/farmacologia , Eritrosina/farmacologia , Glucose/metabolismo , Hidrólise , Ácido Linoleico/metabolismo , Metabolismo dos Lipídeos , Ácido Oleico/metabolismo , ATPases Translocadoras de Prótons/antagonistas & inibidores , Vanadatos/farmacologia
11.
Microbiology (Reading) ; 143(10): 3165-3174, 1997 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-33752284

RESUMO

Plasma membrane vesicles from erg11 and erg2 sterol-deficient mutants and from wild-type Ustilago maydis sporidia treated with and without inhibitors of sterol 14α-demethylase or sterol ∆8-∆7 isomerase (triadimenol and fenpropimorph fungicides, respectively) were purified by aqueous two-phase partitioning. Changes in plasma membrane lipid composition were mostly restricted to sterols and complex lipid-bound fatty acids (CLB fatty acids). There was a greater accumulation of abnormal sterols (14α-methyl-or ∆ 8-unsaturated sterols) in plasma membranes from sterol-deficient mutants than from those treated with their fungicide counterparts. However, greater growth inhibition was observed on fungicide-treated wild-type than on mutants. Changes in CLB fatty acids were restricted to alterations in the relative proportion of linoleic acid (18:2) with respect to oleic acid (18:1). The 18:2 to 18:1 ratio found in CLB fatty acids in plasma membranes could be correlated to rates of sporidial growth but not to accumulation of a particular abnormal sterol or to the extent of sterol replacement. Plasma membrane permeability to protons was increased moderately in the mutants only. No changes were observed in plasma membrane fluidity. Plasma membrane H+-ATPase activity was increased up to twofold in those cases with lower growth rate. It was concluded that fungicide-induced growth inhibition in U. maydis was not due to accumulation of abnormal sterols in plasma membranes but probably due to intracellular ATP depletion by the H+-ATPase and that changes in 18:2 to 18:1 ratio in CLB fatty acids were not directly dependent on the plasma membrane physical state or lipid composition but were possibly part of a stress adaptation mechanism.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA